1. Liver and gastrointestinal cancers
   Jose J.G. Marin et al, 2020, Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy CrossRef
2. Therapeutic Effects of Curcumin Against Colorectal Cancer
   Christoffer Briggs Lambring et al, 2020, Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers CrossRef
3. New uracil analogs as downregulators of ABC transporters in 5-fluorouracil-resistant human leukemia HL-60 cell line
   Angelika Długosz-Pokorska et al, 2019, Molecular Biology Reports CrossRef
4. ABC Transporter-Mediated Multidrug-Resistant Cancer
   Haneen Amawi et al, 2019, Drug Transporters in Drug Disposition, Effects and Toxicity CrossRef
5. Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines
   Ga-Young Lee et al, 2021, Chinese Journal of Integrative Medicine CrossRef
6. A multidrug resistance‐associated protein inhibitor is a potential enhancer of the benzyl isothiocyanate‐induced apoptosis induction in human colorectal cancer cells
   Qifu Yang et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
7. Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?
   Laura Layos et al, 2022, International Journal of Molecular Sciences CrossRef
8. Therapeutic Applications of Curcumin and Derivatives in Colorectal Cancer
   Christoffer Lambring et al, 2022, Onco Therapeutics CrossRef
9. Proteomic investigations into resistance in colorectal cancer
   David I. Cantor et al, 2020, Expert Review of Proteomics CrossRef
10. GSTs, MRP and Apoptototic Markers in DLD-1 Human Colon Cancer Cell Line Before and After 5-FU Treatment
    Fatıma Nurdan GÜRBÜZ et al, 2022, International Journal of Nature and Life Sciences CrossRef
11. Silencing of TMEM158 Inhibits Tumorigenesis and Multidrug Resistance in Colorectal Cancer
    Lihua Liu et al, 2020, Nutrition and Cancer CrossRef
12. Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer
    Francisco Quiñonero et al, 2023, Applied Sciences CrossRef
13. A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy
    Zhao Li et al, 2022, Drug Delivery CrossRef
14. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
    Jose Marin et al, 2022, Cancers CrossRef
15. Oxaliplatin and its derivatives – An overview
    Paul D. O'Dowd et al, 2023, Coordination Chemistry Reviews CrossRef
16. Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier
    Carlos Martins-Gomes et al, 2023, Journal of Xenobiotics CrossRef
17. Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
    Jose J.G. Marin et al, 2020, Cancers CrossRef
18. Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?
    María Bucci-Muñoz et al, 2023, Life CrossRef
19. New Insights into Chemoresistance Mediated by Mdm2 Inhibitors: The Benefits of Targeted Therapy over Common Cytostatics
    Tatyana Grigoreva et al, 2024, Biomedicines CrossRef
20. Cepharanthine combined with 5-fluorouracil inhibits the growth of p53-mutant human colorectal cancer cells
    Sukanya Unson et al, 2020, Journal of Asian Natural Products Research CrossRef
21. Babao Dan Reverses Multiple-Drug Resistance in Gastric Cancer Cells via Triggering Apoptosis and Autophagy and Inhibiting PI3K/AKT/mTOR Signaling
    Jinyan Zhao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
22. BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT 116 colorectal cancer cells
    Yi Jer Tan et al, 2021, Life Sciences CrossRef